MedTrace Logo

Effect of Levosimendan on Respiratory Muscle Function in Healthy Subjects

NCT01101620 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2011-01-20

No results posted yet for this study

Summary

The purpose of this study is to investigate if levosimendan improves contractile performance of the diaphragm in healthy subjects.

Conditions

  • Respiratory Muscle Function

Interventions

DRUG

Levosimendan

Sponsors & Collaborators

  • Orion Corporation, Orion Pharma

    collaborator INDUSTRY

  • University Medical Center Nijmegen

    lead OTHER

Principal Investigators

  • Leo Heunks, MD · University Medical Center Nijmegen

  • Jonne Doorduin · University Medical Center Nijmegen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2010-09-30
Completion
2010-09-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01101620 on ClinicalTrials.gov